{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T15:19:09Z","timestamp":1759331949724},"reference-count":37,"publisher":"Oxford University Press (OUP)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mod Rheumatol"],"published-print":{"date-parts":[[2010,4]]},"DOI":"10.1007\/s10165-009-0246-1","type":"journal-article","created":{"date-parts":[[2009,11,13]],"date-time":"2009-11-13T12:15:57Z","timestamp":1258114557000},"page":"154-159","source":"Crossref","is-referenced-by-count":3,"title":["Raised concentration of soluble form of vascular endothelial cadherin and IL-23 in sera of patients with Beh\u00e7et\u2019s disease"],"prefix":"10.1093","volume":"20","author":[{"given":"Zahra","family":"Habibagahi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mojtaba","family":"Habibagahi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masoomeh","family":"Heidari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2009,11,14]]},"reference":[{"key":"246_CR1","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s10238-004-0045-0","volume":"4","author":"SA Al-Mutawa","year":"2004","unstructured":"Al-Mutawa SA, Hegab SM. Behcet\u2019s disease. Clin Exp Med. 2004;4:103\u201331.","journal-title":"Clin Exp Med"},{"key":"246_CR2","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s10238-004-0033-4","volume":"4","author":"M Suzuki Kurokawa","year":"2004","unstructured":"Suzuki Kurokawa M, Suzuki N. Behcet\u2019s disease. Clin Exp Med. 2004;4:10\u201320.","journal-title":"Clin Exp Med"},{"key":"246_CR3","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/S0022-3476(98)70368-3","volume":"132","author":"I Kone-Paut","year":"1998","unstructured":"Kone-Paut I, Yurdakul S, Bahabri SA, Shafae N, Ozen S, Ozdogan H, et al. Clinical features of Behcet\u2019s disease in children: an international collaborative study of 86 cases. J Pediatr. 1998;132:721\u20135.","journal-title":"J Pediatr"},{"key":"246_CR4","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/0003-9969(95)00042-N","volume":"40","author":"S Narikawa","year":"1995","unstructured":"Narikawa S, Suzuki Y, Takahashi M, Furukawa A, Sakane T, Mizushima Y. Streptococcus oralis previously identified as uncommon \u2018Streptococcus sanguis\u2019 in Behcet\u2019s disease. Arch Oral Biol. 1995;40:685\u201390.","journal-title":"Arch Oral Biol"},{"key":"246_CR5","first-page":"S19","volume":"19","author":"E Eksioglu-Demiralp","year":"2001","unstructured":"Eksioglu-Demiralp E, Direskeneli H, Kibaroglu A, Yavuz S, Ergun T, Akoglu T. Neutrophil activation in Behcet\u2019s disease. Clin Exp Rheumatol. 2001;19:S19\u201324.","journal-title":"Clin Exp Rheumatol"},{"key":"246_CR6","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1093\/rheumatology\/35.5.424","volume":"35","author":"S Sahin","year":"1996","unstructured":"Sahin S, Lawrence R, Direskeneli H, Hamuryudan V, Yazici H, Akoglu T. Monocyte activity in Behcet\u2019s disease. Br J Rheumatol. 1996;35:424\u20139.","journal-title":"Br J Rheumatol"},{"key":"246_CR7","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1136\/ard.55.2.128","volume":"55","author":"S Sahin","year":"1996","unstructured":"Sahin S, Akoglu T, Direskeneli H, Sen LS, Lawrence R. Neutrophil adhesion to endothelial cells and factors affecting adhesion in patients with Behcet\u2019s disease. Ann Rheum Dis. 1996;55:128\u201333.","journal-title":"Ann Rheum Dis"},{"key":"246_CR8","first-page":"1915","volume":"112","author":"PL Hordijk","year":"1999","unstructured":"Hordijk PL, Anthony E, Mul FP, Rientsma R, Oomen LC, Roos D. Vascular-endothelial-cadherin modulates endothelial monolayer permeability. J Cell Sci. 1999;112:1915\u201323.","journal-title":"J Cell Sci"},{"key":"246_CR9","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1084\/jem.186.4.517","volume":"186","author":"JR Allport","year":"1997","unstructured":"Allport JR, Ding H, Collins T, Gerritsen ME, Luscinskas FW. Endothelial-dependent mechanisms regulate leukocyte transmigration: a process involving the proteasome and disruption of the vascular endothelial-cadherin complex at endothelial cell-to-cell junctions. J Exp Med. 1997;186:517\u201327.","journal-title":"J Exp Med"},{"key":"246_CR10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1253\/circj.68.1","volume":"68","author":"T Soeki","year":"2004","unstructured":"Soeki T, Tamura Y, Shinohara H, Sakabe K, Onose Y, Fukuda N. Elevated concentration of soluble vascular endothelial cadherin is associated with coronary atherosclerosis. Circ J. 2004;68:1\u20135.","journal-title":"Circ J"},{"key":"246_CR11","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1111\/j.1365-3083.2005.01698.x","volume":"62","author":"MV Jonsson","year":"2005","unstructured":"Jonsson MV, Salomonsson S, Oijordsbakken G, Skarstein K. Elevated serum levels of soluble E-cadherin in patients with primary Sjogren\u2019s syndrome. Scand J Immunol. 2005;62:552\u20139.","journal-title":"Scand J Immunol"},{"key":"246_CR12","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1055\/s-0037-1616228","volume":"86","author":"E Dejana","year":"2001","unstructured":"Dejana E, Spagnuolo R, Bazzoni G. Interendothelial junctions and their role in the control of angiogenesis, vascular permeability and leukocyte transmigration. Thromb Haemost. 2001;86:308\u201315.","journal-title":"Thromb Haemost"},{"key":"246_CR13","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1172\/JCI28508","volume":"116","author":"Y Iwakura","year":"2006","unstructured":"Iwakura Y, Ishigame H. The IL-23\/IL-17 axis in inflammation. J Clin Invest. 2006;116:1218\u201322.","journal-title":"J Clin Invest"},{"key":"246_CR14","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.immuni.2005.01.011","volume":"22","author":"MA Stark","year":"2005","unstructured":"Stark MA, Huo Y, Burcin TL, Morris MA, Olson TS, Ley K. Phagocytosis of apoptotic neutrophils regulates granulopoiesis via IL-23 and IL-17. Immunity. 2005;22:285\u201394.","journal-title":"Immunity"},{"key":"246_CR15","first-page":"1078","volume":"335","author":"International Study Group for Behcet\u2019s Disease","year":"1990","unstructured":"International Study Group for Behcet\u2019s Disease. Criteria for diagnosis of Behcet\u2019s disease. Lancet. 1990;335:1078\u201380.","journal-title":"Lancet"},{"key":"246_CR16","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/j.1600-0714.1999.tb02023.x","volume":"28","author":"I Krause","year":"1999","unstructured":"Krause I, Rosen Y, Kaplan I, Milo G, Guedj D, Molad Y, et al. Recurrent aphthous stomatitis in Behcet\u2019s disease: clinical features and correlation with systemic disease expression and severity. J Oral Pathol Med. 1999;28:193\u20136.","journal-title":"J Oral Pathol Med"},{"key":"246_CR17","first-page":"1033","volume":"28","author":"I Krause","year":"2001","unstructured":"Krause I, Mader R, Sulkes J, Paul M, Uziel Y, Adawi M, et al. Behcet\u2019s disease in Israel: the influence of ethnic origin on disease expression and severity. J Rheumatol. 2001;28:1033\u20136.","journal-title":"J Rheumatol"},{"key":"246_CR18","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1080\/03009740600905380","volume":"35","author":"AM Dalghous","year":"2006","unstructured":"Dalghous AM, Freysdottir J, Fortune F. Expression of cytokines, chemokines, and chemokine receptors in oral ulcers of patients with Behcet\u2019s disease (BD) and recurrent aphthous stomatitis is Th1-associated, although Th2-association is also observed in patients with BD. Scand J Rheumatol. 2006;35:472\u20135.","journal-title":"Scand J Rheumatol"},{"key":"246_CR19","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1007\/s00296-007-0367-9","volume":"27","author":"A Kulaber","year":"2007","unstructured":"Kulaber A, Tugal-Tutkun I, Yentur SP, kman-Demir G, Kaneko F, Gul A, et al. Pro-inflammatory cellular immune response in Behcet\u2019s disease. Rheumatol Int. 2007;27:1113\u20138.","journal-title":"Rheumatol Int"},{"key":"246_CR20","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1002\/art.20334","volume":"50","author":"AM Ben","year":"2004","unstructured":"Ben AM, Houman H, Miled M, Dellagi K, Louzir H. Involvement of chemokines and Th1 cytokines in the pathogenesis of mucocutaneous lesions of Behcet\u2019s disease. Arthritis Rheum. 2004;50:2291\u20135.","journal-title":"Arthritis Rheum"},{"key":"246_CR21","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s10384-007-0473-y","volume":"51","author":"N Mizuki","year":"2007","unstructured":"Mizuki N, Meguro A, Tohnai I, Gul A, Ohno S, Mizuki N. Association of major histocompatibility complex Class I chain-related Gene A and HLA-B Alleles with Behcet\u2019s disease in Turkey. Jpn J Ophthalmol. 2007;51:431\u20136.","journal-title":"Jpn J Ophthalmol"},{"key":"246_CR22","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1136\/ard.2007.079871","volume":"67","author":"A Meguro","year":"2008","unstructured":"Meguro A, Ota M, Katsuyama Y, Oka A, Ohno S, Inoko H, et al. Association of the toll-like receptor 4 gene polymorphisms with Behcet\u2019s disease. Ann Rheum Dis. 2008;67:725\u20137.","journal-title":"Ann Rheum Dis"},{"key":"246_CR23","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.clim.2008.06.006","volume":"129","author":"S Hou","year":"2008","unstructured":"Hou S, Yang P, Du L, Zhou H, Lin X, Liu X, et al. SUMO4 gene polymorphisms in Chinese Han patients with Behcet\u2019s disease. Clin Immunol. 2008;129:170\u20135.","journal-title":"Clin Immunol"},{"key":"246_CR24","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/S1074-7613(00)00070-4","volume":"13","author":"B Oppmann","year":"2000","unstructured":"Oppmann B, Lesley R, Blom B, Timans JC, Xu Y, Hunte B, et al. Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity. 2000;13:715\u201325.","journal-title":"Immunity"},{"key":"246_CR25","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.cyto.2007.09.009","volume":"41","author":"Z Chen","year":"2008","unstructured":"Chen Z, O\u2019Shea JJ. Regulation of IL-17 production in human lymphocytes. Cytokine. 2008;41:71\u20138.","journal-title":"Cytokine"},{"key":"246_CR26","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1111\/j.1365-2796.2008.01950.x","volume":"263","author":"KJ Maloy","year":"2008","unstructured":"Maloy KJ. The Interleukin-23\/Interleukin-17 axis in intestinal inflammation. J Intern Med. 2008;263:584\u201390.","journal-title":"J Intern Med"},{"key":"246_CR27","doi-asserted-by":"crossref","first-page":"5183","DOI":"10.4049\/jimmunol.181.8.5183","volume":"181","author":"VS von","year":"2008","unstructured":"von VS, Ley K. Homeostatic regulation of blood neutrophil counts. J Immunol. 2008;181:5183\u20138.","journal-title":"J Immunol"},{"key":"246_CR28","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/j.1365-2133.2007.08403.x","volume":"158","author":"W Lew","year":"2008","unstructured":"Lew W, Chang JY, Jung JY, Bang D. Increased expression of interleukin-23 p19 mRNA in erythema nodosum-like lesions of Behcet\u2019s disease. Br J Dermatol. 2008;158:505\u201311.","journal-title":"Br J Dermatol"},{"key":"246_CR29","doi-asserted-by":"crossref","first-page":"3058","DOI":"10.1167\/iovs.07-1390","volume":"49","author":"W Chi","year":"2008","unstructured":"Chi W, Zhu X, Yang P, Liu X, Lin X, Zhou H, et al. Upregulated IL-23 and IL-17 in Behcet patients with active uveitis. Invest Ophthalmol Vis Sci. 2008;49:3058\u201364.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"246_CR30","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.tcb.2008.10.001","volume":"19","author":"D Vestweber","year":"2009","unstructured":"Vestweber D, Winderlich M, Cagna G, Nottebaum AF. Cell adhesion dynamics at endothelial junctions: VE-cadherin as a major player. Trends Cell Biol. 2009;19:8\u201315.","journal-title":"Trends Cell Biol"},{"key":"246_CR31","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1042\/BST0360203","volume":"36","author":"S Garrido-Urbani","year":"2008","unstructured":"Garrido-Urbani S, Bradfield PF, Lee BP, Imhof BA. Vascular and epithelial junctions: a barrier for leucocyte migration. Biochem Soc Trans. 2008;36:203\u201311.","journal-title":"Biochem Soc Trans"},{"key":"246_CR32","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1242\/jcs.022681","volume":"121","author":"P Turowski","year":"2008","unstructured":"Turowski P, Martinelli R, Crawford R, Wateridge D, Papageorgiou AP, Lampugnani MG, et al. Phosphorylation of vascular endothelial cadherin controls lymphocyte emigration. J Cell Sci. 2008;121:29\u201337.","journal-title":"J Cell Sci"},{"key":"246_CR33","first-page":"583","volume":"110","author":"U Gotsch","year":"1997","unstructured":"Gotsch U, Borges E, Bosse R, Boggemeyer E, Simon M, Mossmann H, et al. VE-cadherin antibody accelerates neutrophil recruitment in vivo. J Cell Sci. 1997;110:583\u20138.","journal-title":"J Cell Sci"},{"key":"246_CR34","doi-asserted-by":"crossref","first-page":"2770","DOI":"10.1182\/blood-2008-03-147181","volume":"112","author":"P Alcaide","year":"2008","unstructured":"Alcaide P, Newton G, Auerbach S, Sehrawat S, Mayadas TN, Golan DE, et al. p120-Catenin regulates leukocyte transmigration through an effect on VE-cadherin phosphorylation. Blood. 2008;112:2770\u20139.","journal-title":"Blood"},{"key":"246_CR35","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1091\/mbc.9.6.1589","volume":"9","author":"B Herren","year":"1998","unstructured":"Herren B, Levkau B, Raines EW, Ross R. Cleavage of beta-catenin and plakoglobin and shedding of VE-cadherin during endothelial apoptosis: evidence for a role for caspases and metalloproteinases. Mol Biol Cell. 1998;9:1589\u2013601.","journal-title":"Mol Biol Cell"},{"key":"246_CR36","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1093\/humrep\/dem429","volume":"23","author":"A Villasante","year":"2008","unstructured":"Villasante A, Pacheco A, Pau E, Ruiz A, Pellicer A, Garcia-Velasco JA. Soluble vascular endothelial-cadherin levels correlate with clinical and biological aspects of severe ovarian hyperstimulation syndrome. Hum Reprod. 2008;23:662\u20137.","journal-title":"Hum Reprod"},{"key":"246_CR37","doi-asserted-by":"crossref","first-page":"4339","DOI":"10.1210\/en.2002-220204","volume":"143","author":"R Gomez","year":"2002","unstructured":"Gomez R, Simon C, Remohi J, Pellicer A. Vascular endothelial growth factor receptor-2 activation induces vascular permeability in hyperstimulated rats, and this effect is prevented by receptor blockade. Endocrinology. 2002;143:4339\u201348.","journal-title":"Endocrinology"}],"container-title":["Modern Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.1007\/s10165-009-0246-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,9]],"date-time":"2022-03-09T16:27:20Z","timestamp":1646843240000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10165-009-0246-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,11,14]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,4]]}},"alternative-id":["246"],"URL":"https:\/\/doi.org\/10.1007\/s10165-009-0246-1","relation":{},"ISSN":["1439-7595","1439-7609"],"issn-type":[{"value":"1439-7595","type":"print"},{"value":"1439-7609","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,11,14]]}}}